About Activaero
Activaero is a Media & Entertainment company based in Gemunden (Germany) founded in 2004, and was acquired by Vectura in March 2014. Controlled breathing technologies for inhaler devices were developed. It operates in the Media & Entertainment and Healthcare sectors. Activaero has raised $22.59 million across 2 funding rounds from investors including Phillips Medisize, Life Sciences Partners and Vesalius Biocapital Partners. Activaero offers products and services including Article Content and Product Reviews. Its focus areas include Life Sciences, Pulmonology, Medical Devices and Therapeutic Devices.
Company details
Activaero was founded in 2004 in Gemunden, Germany, within the medical devices sector. Focus was placed on controlled breathing technologies for pulmonary delivery of inhaled therapeutics. Key products included the AKITA device, which incorporated smart card technology, and the Watchhaler, adapted for pediatric use. Operations centered on innovation in inhalation systems until acquisition by Vectura in 2014.
- Headquarters Gemunden, Germany
- Stage Acquired
- SectorsMedia & EntertainmentHealthcare
- Website activaero.de
- Social LinkedIn
- Acquired by Vectura (Mar 2014)
- Total Equity Funding$22.59M (USD)
in 2 rounds
- Latest Funding Round$6.76M (USD), Series A
Feb 2011
- InvestorsPhillips Medisize
& 6 more
- Acquired byVectura
(Mar 2014)
Products & Services of Activaero
Activaero offers a comprehensive portfolio of products and services, including Article Content and Product Reviews.
Platform for science and health articles providing practical advice.
Reviews of items like screen protectors and home tools.
Funding Insights of Activaero
Activaero has successfully raised a total of $22.59M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $6.76 million completed in February 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $22.59M
- Total Rounds 2
- Last Round Series A — $6.76M
- First Round $15.83M
(Nov 2009)
- Investors Count 6
All 2 funding rounds of Activaero with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2011 | $6.76M | Series A | – | Life Sciences Partners | |
| Nov 2009 | $15.83M | Series A | – | – |
7 investors in total: 7 institutional.
Investors in Activaero
Activaero has secured backing from 7 investors, including venture fund investors. Prominent investors backing the company include Phillips Medisize, Life Sciences Partners and Vesalius Biocapital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early to mid stage life sciences-focused VC firm investing in geographies such as Europe | biomedvc.com | Basel, Switzerland | ||
Investment services are offered by Abalis Finance AG. | 2006 | abalis.ch | Binningen, Switzerland | |
Life sciences-focused VC firm investing in Europe and Canada | 2007 | vesaliusbiocapital.com | Strassen, Luxembourg | |
Life sciences sector focused VC firm funding companies in the US | medven.com | Emeryville, United States | ||
Early-stage venture capital is invested in US and Europe. | vipartners.ch | Altendorf, Switzerland | ||
Private equity investments in life sciences businesses are managed. | 1998 | lspvc.com | Amsterdam, Netherlands | |
Inhaled therapeutics for respiratory diseases are developed. | 1997 | vectura.com | Chippenham, United Kingdom |
Investor details for Activaero
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Activaero
4 dated milestones of Activaero across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Activaero is founded.
- Funding First funding round of $15.8M.
- Funding Latest funding round, Series A, of $6.8M.
- Exit Acquired by Vectura.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Activaero
Activaero was founded in 2004 and raised its 1st funding round 5 years after it was founded.
Activaero is headquartered in Gemunden, Germany. It is registered at Gemunden, Bayern, Germany.
Activaero is a funded company, having raised a total of $22.59M across 2 funding rounds to date. The company's 1st funding round was a Series A of $15.83M, raised on Nov 2009.
Activaero was founded in 2004 in Gemunden, Germany, within the medical devices sector. Focus was placed on controlled breathing technologies for pulmonary delivery of inhaled therapeutics. Key products included the AKITA device, which incorporated smart card technology, and the Watchhaler, adapted for pediatric use. Operations centered on innovation in inhalation systems until acquisition by Vectura in 2014.
Activaero offers Article Content and Product Reviews.
Activaero has 7 investors. Key investors include Phillips Medisize, Life Sciences Partners, Vesalius Biocapital Partners, BioMedPartners, and Abalis.
Yes. Activaero was acquired by Vectura in March 2014.